These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7060182)

  • 1. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
    Rektor L; Blazek J
    Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 4. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
    Populin M; De Vanna M; Poldrugo F
    Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
    Lambert PA; Midenet M; Marcou G; Bouchardy M
    J Med Lyon; 1967 Mar; 48(116):351-5. PubMed ID: 5614941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
    Bohacek N; Mihovilović M
    Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
    Tan CT; Ong TC; Chee KT
    Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 14. Depot neuroleptics in the treatment of acute psychoses.
    Guarneri M; Placidi GF; Cassano GB
    Encephale; 1979; 5(2):189-93. PubMed ID: 477594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
    La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
    Tegeler J; Lehmann E; Stockschlaeder M
    Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)].
    Martin A; Masson JM; Quentin JC; Verrier JP; Jusseaume P
    Ann Med Psychol (Paris); 1972 Dec; 2(5):705-8. PubMed ID: 4576210
    [No Abstract]   [Full Text] [Related]  

  • 19. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.